AI assistant
NEKTAR THERAPEUTICS — Director's Dealing 2010
Feb 3, 2010
32134_dirs_2010-02-03_a1511d59-a746-48b0-b681-c96a151317c4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2010-02-01
Reporting Person: GREER R SCOTT (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-01 | Stock Option | $11.34 | A | 22500 | Acquired | 2018-02-01 | Common Stock (22500) | Direct |
| 2010-02-01 | Stock Option | $11.34 | A | 10000 | Acquired | 2018-02-01 | Common Stock (10000) | Direct |
| 2010-02-01 | Restricted Stock Unit | $0.01 | A | 7500 | Acquired | Common Stock (7500) | Direct | |
| 2010-02-01 | Restricted Stock Unit | $0.01 | A | 3333 | Acquired | Common Stock (3333) | Direct |
Footnotes
F1: The shares subject to this stock option vest on a monthly pro-rata basis over a period of three (3) years commencing on February 1, 2010 (Mr. Greer's date of appointment to the Board of Directors) and ending on February 1, 2013.
F2: The shares subject to this stock option vest on a monthly pro-rata basis over a period of eight (8) months commencing on February 1, 2010 and ending on September 30, 2010.
F3: The shares subject to this restricted stock unit vest on a monthly pro-rata basis over a period of three (3) years commencing on February 1, 2010 and ending on February 1, 2013.
F4: Not applicable.
F5: The shares subject to this restricted stock unit vest on a monthly pro-rata basis over a period of eight (8) months commencing on February 1, 2010 and ending on September 30, 2010.